Literature DB >> 24727548

Prevalence of the sickle cell trait in Gabon: a nationwide study.

Lucrèce M Délicat-Loembet1, Eric Elguero2, Céline Arnathau3, Patrick Durand3, Benjamin Ollomo4, Simon Ossari4, Jérôme Mezui-me-ndong4, Thélesfort Mbang Mboro4, Pierre Becquart3, Dieudonné Nkoghe4, Eric Leroy1, Lucas Sica4, Jean-Paul Gonzalez5, Franck Prugnolle1, François Renaud1.   

Abstract

Sickle Cell Disease (SCD) is an important cause of death in young children in Africa, which the World Health Organization has declared a public health priority. Although SCD has been studied at the continental scale and at the local scale, a picture of its distribution at the scale of an African country has never been given. The aim of this study is to provide such a picture for the Republic of Gabon, a country where precisely the epidemiology of SCD has been poorly investigated. To this effect, 4250 blood samples from persons older than 15 were collected between June 2005 and September 2008 in 210 randomly selected villages from the nine administrative provinces of Gabon. Two methods were used to screen Sickle Cell Trait (SCT) carriers: isoelectric focusing (IEF) and high-performance liquid chromatography (HPLC). SCT prevalence in Gabon was 21.1% (895/4249). SCT prevalence was significantly larger for the Bantu population (21.7%, n=860/3959) than for the Pygmy population (12.1%, n=35/290), (p=0.00013). In addition, the presence of Plasmodium sp. was assessed via thick blood examination. Age was positively associated with SCT prevalence (odds-ratio for an increase of 10 years in age=1.063, p=0.020). Sex was not associated with SCT prevalence. The study reveals the absence of homozygous sickle-cell patients, and marked differences in SCT prevalence between the Gabonese provinces, and also between population groups (Bantu vs Pygmy). These findings could be used by the public health authorities to allocate medical resources and target prevention campaigns.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bantu; Ecology; Evolution; Gabon; Pygmy; Sickle Cell Disease

Mesh:

Substances:

Year:  2014        PMID: 24727548     DOI: 10.1016/j.meegid.2014.04.003

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  5 in total

1.  Malaria continues to select for sickle cell trait in Central Africa.

Authors:  Eric Elguero; Lucrèce M Délicat-Loembet; Virginie Rougeron; Céline Arnathau; Benjamin Roche; Pierre Becquart; Jean-Paul Gonzalez; Dieudonné Nkoghe; Lucas Sica; Eric M Leroy; Patrick Durand; Francisco J Ayala; Benjamin Ollomo; François Renaud; Franck Prugnolle
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

2.  High level of heterozygous haplotype of hemoglobin in Abidjan population with mild malaria.

Authors:  Tosséa A Stéphane Koui; Alloh Albert Gnondjui; Adji Eric Gbessi; Ako Aristide Bérenger Ako; Baba Coulibaly; A Delpêche Aka; Bi Sery E Gonedele; Offiana André Toure; Ronan Jambou
Journal:  BMC Med Genomics       Date:  2022-05-23       Impact factor: 3.622

3.  Cross sectional study on prevalence of sickle cell alleles S and C among patients with mild malaria in Ivory Coast.

Authors:  Stephane Koui Tossea; Eric Gbessi Adji; Baba Coulibaly; Berenger Ako Ako; David Ngolo Coulibaly; Philippe Joly; Serge-Brice Assi; Andre Toure; Ronan Jambou
Journal:  BMC Res Notes       Date:  2018-04-02

4.  Significantly elevated foetal haemoglobin levels in individuals with glucose 6-phosphate dehydrogenase disease and/or sickle cell trait: a cross-sectional study in Cape Coast, Ghana.

Authors:  Patrick Adu; Essel K M Bashirudeen; Florence Haruna; Edward Morkporkpor Adela; Richard K D Ephraim
Journal:  BMC Hematol       Date:  2017-09-25

5.  Exposure to Ebola Virus and Risk for Infection with Malaria Parasites, Rural Gabon.

Authors:  Jessica L Abbate; Pierre Becquart; Eric Leroy; Vanessa O Ezenwa; Benjamin Roche
Journal:  Emerg Infect Dis       Date:  2020-02-17       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.